QurAlis Corp.

ACTIVE

马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.quralis.comHolding101–250 employeesEstablished: 2016-12-12

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Completed

28.6%

Recruiting

71.4%

Clinical Trials

Trials sponsored by this organization (7)

A randomized, placebo-controlled, double blind, multiple ascending dose, phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of QRL-101 in healthy participants

Phase 1

Recruiting

interventional

May 202460 participants

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF QRL-201 IN AMYOTROPHIC LATERAL SCLEROSIS

Phase 1

Recruiting

interventional

Jan 202395 participants

A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants

Phase 1

Recruiting

48 participants

A study on the effects of a new drug on the sensitivity of the nerves in healthy volunteers

Phase 1

Completed

24 participants

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF QRL-201 IN AMYOTROPHIC LATERAL SCLEROSIS

Phase 1

Recruiting

35 participants

A Randomized, Placebo-Controlled, Double-Blind, Single Dose, Phase 1 Study to Explore the PK/PD Relationship of QRL-101 in People Living With ALS

Phase 1

Recruiting

12 participants

A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants

Phase 1

Completed

24 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations